Big Board

Entertainment
Sports
Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Experimental HIV vaccine regimen ineffective in preventing HIV | National Institutes of Health
2 HVTN and HPTN initiate first clinical trial in response to COVID-19
3 Skilled partners in the conduct of HIV prevention trials join COVID-19 response
4 NIH and partners to launch HIV vaccine efficacy trial in the Americas and Europe
5 Experts share insights on coronavirus vaccines at Fred Hutch virtual event
6 HVTN study confirms correlates of risk associated with decrease in HIV transmission
7 HIV Vaccine Trial Halted After 10 Years And $100 Million : Goats and Soda
8 HIV vaccine trial failure is a “wake up call” for southern Africa, say researchers
9 Is there an AIDS vaccine? Trump may think it exists, but here's a look at the actual status of the vaccine
10 [Op-ed]: New PrEP injection testament to HIV research and community partnership
11 HIV vaccine in 2021? Leading experts 'optimistic' about ongoing trials
12 An old HIV vaccine surprises researchers once again
13 HIV Vaccine Candidate Included in HVTN 132 Study
14 Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
15 Study demonstrates antibody responses within 6 weeks of initial vaccination
16 Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial
17 How Has the COVID-19 Pandemic Affected HIV Vaccine Trials?
18 Combo of two HIV vaccines fails its big test
19 Good News, Bad News in HIV Prevention Research
20 NIH and partners launch HIV vaccine efficacy study
21 NIAID Observes HIV Vaccine Awareness Day 2020
22 HIV Vaccine Trial Halted After No Efficacy Observed
23 An Introduction to Vaccine Challenges: Part 4
24 GeoVax Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial
25 The search for an effective HIV vaccine continues
26 GeoVax to Participate in International Webinar Focused on the State of COVID-19 Vaccines
27 New HIV vaccine trial to launch in US, Latin America and Europe
28 First new HIV vaccine efficacy study in seven years has begun
29 Large-scale HIV vaccine trial to launch in South Africa
30 HIV Vaccine Efficacy Trial Mosaico to Launch in Americas, Europe
31 HIV Vaccine Trial Ends in 'Disappointment' but Provides Valuable Data
32 Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials
33 Cross-clade immune responses reported in South African RV144 HIV vaccine regimen
34 HIV vaccine that generates broadly neutralising antibodies passes first safety and proof-of-concept study in humans
35 Q&A: Dr. Larry Corey at the center of COVID-19 vaccine research
36 Large Trial of HIV Vaccine Finds It Does Not Prevent HIV
37 HIV Vaccine Could Be Available in 2021, Expert Says
38 GeoVax to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research
39 HIV Vaccine Trials Group Steps Up to the COVID-19 Plate
40 Rectal microbes influence effectiveness of HIV vaccine
41 'Cautiously optimistic about HIV vaccines'
42 It's all go for a new HIV vaccine efficacy trial this year
43 Another HIV vaccine efficacy trial will start this year
44 New HIV vaccine could soon be clinically tested in SA
45 A Reliable HIV Vaccine: When Will it Happen?
46 Promising HIV vaccine to be tested with gay men and trans people
47 GeoVax Presents HIV Vaccine Study Data OTC Markets:GOVX
48 Study points toward progress on TB vaccines
49 With Uhambo's and research lessons, once more unto the breach
50 Hope for an HIV vaccine not lost after one drug proves ineffective
51 Morning Break: Coronavirus 'Pandemic'; Black Box $$$; Avocado Super Bowl Injuries
52 GSK culls oncology hopeful, officially tosses out failed HIV vax
53 sponsored HIV vaccine trial launches in South Africa
54 It’s Mad, Mad, Mad, Mad Race
55 HIV Vaccine Combo Produced Antibody Responses Within 6 Weeks
56 On World AIDS Day, renewed hope for an HIV vaccine
57 Why HIV vaccine trials were stopped in SA
58 We'll only rest once we get vaccine, say experts despite failed test
59 GeoVax Provides Update on HIV Clinical Trials Program
60 Training tomorrow's HIV researchers
61 New study shows response to HIV vaccine in 6 weeks
62 Developing a vaccine against HIV infection
63 A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa
64 HIV Vaccine Needed To Stop AIDS : Shots
65 NIH Says Experimental HIV Vaccine Has Been Found Ineffective
66 COVID-19 Laboratory Challenges and Lessons: Part 1
67 The pride of Fred Hutch
68 Is the world ready for an HIV vaccine?
69 GeoVax Reports 2019 Year-End Financial Results And Provides Corporate Update
70 RV144 HIV Vaccine — Precision Vaccinations
71 NIH statement on HIV Vaccine Awareness Day
72 HIV vaccine: Clinical trial begins in South Africa
73 Jim Kublin, MD, MPH
74 Is There a Future for Effective Vaccines for Infectious Diseases?
75 J&J passes key milestone in HIV vaccine trial
76 GeoVax Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11
77 Inovio HIV Vaccine PENNVAX®-GP Delivered Intradermally Generated Robust, Long-Term Best-In-Class Antibody and T Cell Immune Responses
78 Vaccine Development
79 HIV vaccine shows signs of cross-subtype protection
80 Creating viral targets can weaken HIV vaccination
81 Is the Secret for Potential HIV Vaccines Hiding in Our Butts?
82 US funding agency upbeat about HIV research despite SA vaccine failure
83 Spotlight: Cool techs we can't wait to see in 2020
84 UMass Researchers Move Into Phase 1 Trial with HIV Vaccine
85 Enlisting the microbiome in the quest for an AIDS vaccine
86 Top medical professionals condemn suspension of Professor Ebrahim Variava
87 GeoVax Provides Update on Its HIV Vaccine Program | Vaccines | News Channels
88 Reuters Health News Summary
89 What the discovery of a new HIV strain means for the pandemic
90 HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine | Vaccines | News Channels
91 HIV Vaccine Candidate Generated Near 100% Immune Responses
92 Effects of influenza vaccination on seasonal influenza symptoms: A prospective observational study in elementary schoolchildren in Japan.
93 Meet Peru's HIV superhero
94 HIV vaccine failure, coronavirus papers and an unprecedented glimpse of the Sun
95 Cautious optimism for an HIV vaccine | December 5, 2016 Issue
96 Institutes, Networks & IRCs
97 GOVX: Coronavirus Collaboration Could Validate Platform
98 'Mosaic' Vax Proves Mettle Against More HIV Subtypes
99 GeoVax Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress
100 More volunteers needed to test new HIV vaccine